Occult testicular leukemia in a patient with acute monocytic leukemia.
Nishikawa
A
A
Kansai Medical University, Department of Pediatrics, Osaka, Japan.
Nobori
U
U
Higashino
H
H
Kobayashi
Y
Y
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002648:Child; D003131:Combined Modality Therapy; D016371:Cranial Irradiation; D003561:Cytarabine / Q000008:administration & dosage / Q000031:analogs & derivatives; D003630:Daunorubicin / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage; D007948:Leukemia, Monocytic, Acute / Q000188:drug therapy / Q000473:pathology* / Q000532:radiotherapy; D008297:Male; D008577:Meningeal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D015122:Mercaptopurine / Q000008:administration & dosage; D008727:Methotrexate / Q000008:administration & dosage; D011241:Prednisone / Q000008:administration & dosage; D012074:Remission Induction; D013736:Testicular Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000532:radiotherapy; D013866:Thioguanine / Q000008:administration & dosage
D003561:Cytarabine; D004317:Doxorubicin; C015019:enocitabine; D015122:Mercaptopurine; D013866:Thioguanine; D011241:Prednisone; D006854:Hydrocortisone; D008727:Methotrexate; D003630:Daunorubicin